Skip to content
PubMed This is a summary of 49 peer-reviewed journal articles Updated
Clinical Immunology · LRBA Deficiency

LRBA Deficiency: A Patient Guide

At a Glance

LRBA deficiency is a rare inherited immune disorder that can cause the immune system to attack the gut, blood cells, and organs while increasing infections. Genetic diagnosis supports targeted care, including abatacept, transplant evaluation, and lifelong monitoring.

LRBA deficiency is an ultra-rare genetic condition that fundamentally changes how the immune system behaves. In a healthy body, the immune system is a precisely balanced machine, capable of revving up to fight a virus and then immediately cooling down once the threat has passed. This cooling-down phase is managed by internal “brakes” that tell immune cells to stop attacking. In those with LRBA deficiency, a missing protein impairs the trafficking and recycling of a key immune brake called CTLA-4, leaving the immune system in a state of variable, uncontrolled overactivity [1][2].

Because these internal brakes are impaired, the immune system often begins to attack the body’s own healthy tissues, a process known as immune dysregulation. This overactivity most commonly manifests in three ways: severe and chronic digestive issues that resemble inflammatory bowel disease, the destruction of the body’s own blood cells, and the swelling of organs like the spleen and liver. Ironically, while the immune system is overactive in its attack on the body, it is often poorly defended against external germs, leading to a cycle of recurrent infections, particularly in the lungs and sinuses [3][4].

Receiving a genetic diagnosis is a pivotal moment because it clarifies that these diverse symptoms are not separate problems, but part of a single underlying cause. This clarity opens the door to targeted therapies, such as abatacept (an off-label medication that mimics some of the missing CTLA-4 inhibitory function), which can significantly improve daily life and stabilize symptoms. For some, a stem cell transplant may even offer the possibility of a permanent cure by providing the body with a functional immune system, though it carries substantial risks [5][6].

Living with LRBA deficiency requires a commitment to lifelong, individualized monitoring. Because the condition can quietly affect the lungs or other organs even when you feel relatively well, regular check-ups and age-appropriate clinical assessment are essential for catching changes early. While the path forward involves many specialists and careful management, the transition from “searching for answers” to “targeted treatment” provides a clearer, more hopeful framework for navigating life with this rare condition [7][8].

Common questions in this guide

What is LRBA deficiency?
LRBA deficiency is an ultra-rare inherited disorder that disrupts the immune system's ability to regulate itself. A missing or impaired LRBA protein affects CTLA-4, an important immune brake, which can lead to attacks on the body's tissues and reduced protection against infections.
What symptoms can LRBA deficiency cause?
People may have severe, chronic digestive problems that resemble inflammatory bowel disease, destruction of blood cells, and enlargement of the spleen or liver. Recurrent infections, especially in the lungs and sinuses, can occur because immune overactivity and problems fighting germs may happen at the same time.
How can a genetic diagnosis change LRBA deficiency care?
A genetic diagnosis can show that digestive, blood, organ, and infection-related problems share one underlying cause. It can help the care team consider targeted treatment and create an individualized plan for monitoring, follow-up, and urgent care.
What treatments are used for LRBA deficiency?
Treatment is individualized. Abatacept may restore some immune-braking function and is used off label, while a hematopoietic stem cell transplant may be considered for some patients but carries substantial risks.
Can a stem cell transplant cure LRBA deficiency?
For some patients, a stem cell transplant may provide a functional immune system and the possibility of a permanent cure. It is a major treatment with substantial risks, so specialists weigh disease severity, overall health, and other options.
What monitoring does someone with LRBA deficiency need?
Lifelong follow-up is important because LRBA deficiency can affect the lungs or other organs even when symptoms are mild. Regular checkups and age-appropriate clinical assessment may include baseline and repeat evaluation of the lungs, digestive system, and other affected organs.

Get notified when new evidence is published on Syndromic autoimmune enteropathy due to LRBA deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (8)
  1. 1

    Exaggerated follicular helper T-cell responses in patients with LRBA deficiency caused by failure of CTLA4-mediated regulation.

    Alroqi FJ, Charbonnier LM, Baris S, et al.

    The Journal of allergy and clinical immunology 2018; (141(3)):1050-1059.e10 doi:10.1016/j.jaci.2017.05.022.

    PMID: 28601686
  2. 2

    Regulation of CTLA-4 recycling by LRBA and Rab11.

    Janman D, Hinze C, Kennedy A, et al.

    Immunology 2021; (164(1)):106-119 doi:10.1111/imm.13343.

    PMID: 33960403
  3. 3

    Clinical, Immunologic, and Molecular Spectrum of Patients with LPS-Responsive Beige-Like Anchor Protein Deficiency: A Systematic Review.

    Habibi S, Zaki-Dizaji M, Rafiemanesh H, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(7)):2379-2386.e5 doi:10.1016/j.jaip.2019.04.011.

    PMID: 30995531
  4. 4

    The extended phenotype of LPS-responsive beige-like anchor protein (LRBA) deficiency.

    Gámez-Díaz L, August D, Stepensky P, et al.

    The Journal of allergy and clinical immunology 2016; (137(1)):223-230 doi:10.1016/j.jaci.2015.09.025.

    PMID: 26768763
  5. 5

    Abatacept as a Long-Term Targeted Therapy for LRBA Deficiency.

    Kiykim A, Ogulur I, Dursun E, et al.

    The journal of allergy and clinical immunology. In practice 2019; (7(8)):2790-2800.e15 doi:10.1016/j.jaip.2019.06.011.

    PMID: 31238161
  6. 6

    Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score.

    Tesch VK, Abolhassani H, Shadur B, et al.

    The Journal of allergy and clinical immunology 2020; (145(5)):1452-1463 doi:10.1016/j.jaci.2019.12.896.

    PMID: 31887391
  7. 7

    Treatment and management of primary antibody deficiency: German interdisciplinary evidence-based consensus guideline.

    Hanitsch L, Baumann U, Boztug K, et al.

    European journal of immunology 2020; (50(10)):1432-1446 doi:10.1002/eji.202048713.

    PMID: 32845010
  8. 8

    Respiratory manifestations in LPS-responsive beige-like anchor (LRBA) protein-deficient patients.

    Shamriz O, Shadur B, NaserEddin A, et al.

    European journal of pediatrics 2018; (177(8)):1163-1172 doi:10.1007/s00431-018-3171-5.

    PMID: 29777306

This page is for informational purposes only and does not constitute medical advice. LRBA deficiency requires individualized monitoring, so discuss abatacept, transplant, and urgent symptoms with your specialist team.